EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

circHIPK2 promotes malignant progression of laryngeal squamous cell carcinoma through the miR-889-3p/MCTS1/IL-6 axis

Yang-Guang Sun, Zhen-Kun Yu, Xi Chen, Si-Yao Zhang, Wan-Juan Wu, Kai Liu, Lei Cheng

Translational Oncology · 2025-06 · 56 · 102390

DOI: 10.1016/j.tranon.2025.102390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2025-06. Verfasst von Yang-Guang Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Commission of Health, Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laryngeal squamous cell carcinoma (LSCC) is a common malignant tumor of the head and neck with a poor prognosis. The role of circRNAs in LSCC remains largely unknown. In this study, quantitative real-time PCR (qRT-PCR), Sanger sequencing and fluorescence in situ hybridization were undertaken to detect the expression, localization, and clinical significance of circHIPK2 in LSCC tissues and TU686 and TU212 cells. The functions of circHIPK2 in LSCC were explored through proliferation analysis, EdU staining, colony formation assay, wound healing assay, and Transwell assay. The regulatory mechanisms underpinning circHIPK2, miR-889-3p, and MCTS1 were investigated using luciferase assay, Western blotting, and qRT-PCR. We found that LSCC tissues and cells demonstrated high expression of circHIPK2 that was closely associated with the malignant progression and poor prognosis of LSCC. Knockdown of circHIPK2 inhibited the proliferation and migration of LSCC cells in vitro. Mechanistic studies showed that circHIPK2 competitively bound to miR-889-3p, elevated MCTS1 level, promoted IL-6 secretion, and ultimately accelerated the malignant progression of LSCC. In conclusion, an axis involving circHIPK2, miR-889-3p, MCTS1 and IL-6 regulates the malignant progression of LSCC. circHIPK2 expression may serve as a novel diagnostic and prognostic biomarker for LSCC.

Schlagwörter

Stichwörter der Autor:innen

IL-6Laryngeal squamous cell carcinomaMCTS1Non-coding RNATumor microenvironmentcircHIPK2miR-889–3p

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Nanjing Medical Key Laboratory of Laryngopharynx-Head & Neck Oncology, Department of Otolaryngology-Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing 210019,…
  • Department of Otorhinolaryngology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Department of Allergology, The First Affiliated Hospital with Nanjing Medical University, Nanjing…

Förderung

  • Jiangsu Commission of Health
  • Nanjing Medical University

Zitieren

APA

Sun, Y. G., Yu, Z. K., Chen, X., Zhang, S. Y., Wu, W. J., Liu, K., & Cheng, L. (2025). circHIPK2 promotes malignant progression of laryngeal squamous cell carcinoma through the miR-889-3p/MCTS1/IL-6 axis. Translational Oncology, 56, 102390. https://doi.org/10.1016/j.tranon.2025.102390

Vancouver

Sun YG, Yu ZK, Chen X, Zhang SY, Wu WJ, Liu K, et al. circHIPK2 promotes malignant progression of laryngeal squamous cell carcinoma through the miR-889-3p/MCTS1/IL-6 axis. Translational Oncology. 2025;56:102390. doi:10.1016/j.tranon.2025.102390

BibTeX
@article{Sun2025,
  author = {Sun, Yang-Guang and Yu, Zhen-Kun and Chen, Xi and Zhang, Si-Yao and Wu, Wan-Juan and Liu, Kai and Cheng, Lei},
  title = {circHIPK2 promotes malignant progression of laryngeal squamous cell carcinoma through the miR-889-3p/MCTS1/IL-6 axis},
  journal = {Translational Oncology},
  year = {2025},
  volume = {56},
  pages = {102390},
  doi = {10.1016/j.tranon.2025.102390}
}
Kostenlos starten →